Sartorius opens new Center of Excellence for bioanalytics in Ann Arbor

2024-06-06
并购
Manufacturing of instruments, consumables and reagents for cell and protein analysis
Consolidation of existing sites and functions in Ann Arbor
Overall investment of around 100 million US dollars
ANN ARBOR, Mich., June 6, 2024 /PRNewswire/ -- The life science group Sartorius today opened its new Center of Excellence for bioanalytics in Ann Arbor, Michigan, two years after breaking ground in the Tech Loop at Research Park. Sartorius has invested around 100 million US dollars in the state-of-the-art facility, consolidating existing sites and functions in Ann Arbor. The number of employees at the site is expected to double over time.
Continue Reading
Sartorius opens new Center of Excellence for bioanalytics in Ann Arbor
Preview
来源: PRNewswire
Sartorius' Center of Excellence in Ann Arbor, Michigan. Photo credit: (c) Melanie Reyes
Sartorius opens new Center of Excellence for bioanalytics in Ann Arbor
Preview
来源: PRNewswire
(L-R) Florian Funck, CFO; Laurent Claisse, Head of Operations of the Lab Products & Services Division; Alexandra Gatzemeyer, Head of the Lab Products & Services Division; Peter Mertens, Project Lead; Maurice Phelan, President of Sartorius North America; Joachim Kreuzburg, CEO. Photo credit: (c) Melanie Reyes
"Sartorius is a leading provider of highly automated bioanalytical solutions that are used in the discovery and development of innovative biopharmaceutical drugs. We are helping scientists to gain better, data-driven insights and streamline their workflows, ultimately accelerating the development of new, life-saving therapies. With our new flagship site in Ann Arbor, we are bringing together our core competencies and dedicated experts under one roof, further strengthening our ability to address key customer needs in this highly innovative and relevant field," said Dr. Alexandra Gatzemeyer, Head of the Lab Products & Services division and member of the Executive Board of Sartorius.
The 130,000-square-foot facility houses a modern manufacturing and services area, biology labs, a warehouse, office and training spaces, as well as a Customer Interaction Center (CIC). Sartorius will develop and manufacture a range of bioanalytical instruments at this site, including the associated reagents, consumables and software solutions. In addition, the company will provide particle validation services and produce microcarriers used in cell culture processes.
The Center of Excellence was built with a focus on sustainability and is seeking a Leadership in Energy and Environmental Design (LEED) gold certification, to be administered by the U.S. Green Building Council. Sustainable features include green electric energy supply from 200 kilowatt solar panels, 30 electric vehicle charging stations, and Research Park's first storm runoff pond.
"Ann Arbor is strategically located at the crossroads of talent, technology and logistics, in close proximity to customers and renowned universities. The opening of our new building in the Tech Loop marks an important milestone for Sartorius in the Americas region, offering space for further expansion in the future," said Maurice Phelan, President of Sartorius North America.
Sartorius has already been present in the city for several years, after acquiring the Ann Arbor-based businesses Essen BioScience in 2017 and SoloHill in 2020. In total, around 2,600 employees work for Sartorius at 12 sites in North America.
A profile of Sartorius
Sartorius (XETRA: SRT3 | SRT) is a leading international partner of life sciences research and biopharmaceutical manufacturing. With innovative laboratory instruments and consumables, the Group's Lab Products & Services division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. The company, based in Göttingen, Germany, has a strong global reach with around 60 production and sales sites worldwide. Sartorius regularly expands its portfolio through the acquisition of complementary technologies. In 2023, the company generated sales revenue of around 3.4 billion euros. Currently, around 14,600 employees are working for customers around the globe.
Visit our Newsroom or follow us on LinkedIn.
Contact
Leona Malorny
Head of External Communications
+49 551 308 4067
[email protected]
SOURCE Sartorius
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
Eureka LS:
全新生物医药AI Agent 覆盖科研全链路,让突破性发现快人一步
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。